These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9619828)

  • 21. Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis.
    Kerfoot C; Wienecke R; Menchine M; Emelin J; Maize JC; Welsh CT; Norman MG; DeClue JE; Vinters HV
    Brain Pathol; 1996 Oct; 6(4):367-75. PubMed ID: 8944308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presence of potent transcriptional activation domains in the predisposing tuberous sclerosis (Tsc2) gene product of the Eker rat model.
    Tsuchiya H; Orimoto K; Kobayashi K; Hino O
    Cancer Res; 1996 Feb; 56(3):429-33. PubMed ID: 8564946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alternative splicing of the tuberous sclerosis 2 (TSC2) gene in human and mouse tissues.
    Xu L; Sterner C; Maheshwar MM; Wilson PJ; Nellist M; Short PM; Haines JL; Sampson JR; Ramesh V
    Genomics; 1995 Jun; 27(3):475-80. PubMed ID: 7558029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced TSC2 RNA and protein in sporadic astrocytomas and ependymomas.
    Wienecke R; Guha A; Maize JC; Heideman RL; DeClue JE; Gutmann DH
    Ann Neurol; 1997 Aug; 42(2):230-5. PubMed ID: 9266734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel TSC2 mutations and decreased expression of tuberin in cultured tumor cells with an insertion mutation.
    Feng JH; Yamamoto T; Nanba E; Ninomiya H; Oka A; Ohno K
    Hum Mutat; 2004 Apr; 23(4):397. PubMed ID: 15024740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The GAP-related domain of tuberin, the product of the TSC2 gene, is a target for missense mutations in tuberous sclerosis.
    Maheshwar MM; Cheadle JP; Jones AC; Myring J; Fryer AE; Harris PC; Sampson JR
    Hum Mol Genet; 1997 Oct; 6(11):1991-6. PubMed ID: 9302281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The tuberous sclerosis 2 gene is expressed at high levels in the cerebellum and developing spinal cord.
    Geist RT; Gutmann DH
    Cell Growth Differ; 1995 Nov; 6(11):1477-83. PubMed ID: 8562486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region.
    Jin F; Wienecke R; Xiao GH; Maize JC; DeClue JE; Yeung RS
    Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9154-9. PubMed ID: 8799170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct effects of single amino-acid changes to tuberin on the function of the tuberin-hamartin complex.
    Nellist M; Sancak O; Goedbloed MA; Rohe C; van Netten D; Mayer K; Tucker-Williams A; van den Ouweland AM; Halley DJ
    Eur J Hum Genet; 2005 Jan; 13(1):59-68. PubMed ID: 15483652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metastasis of benign tumor cells in tuberous sclerosis complex.
    Henske EP
    Genes Chromosomes Cancer; 2003 Dec; 38(4):376-81. PubMed ID: 14566858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for separable functions of tuberous sclerosis gene products in mammalian cell cycle regulation.
    Miloloza A; Kubista M; Rosner M; Hengstschläger M
    J Neuropathol Exp Neurol; 2002 Feb; 61(2):154-63. PubMed ID: 11853018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cell cycle and tuberous sclerosis.
    Hengstschläger M; Rosner M
    Prog Cell Cycle Res; 2003; 5():43-8. PubMed ID: 14593699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tuberous sclerosis in a 19-week fetus: immunohistochemical and molecular study of hamartin and tuberin.
    Wei J; Li P; Chiriboga L; Mizuguchi M; Yee H; Miller DC; Greco MA
    Pediatr Dev Pathol; 2002; 5(5):448-64. PubMed ID: 12202993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of the Rap1 GTPase in astrocyte growth regulation.
    Apicelli AJ; Uhlmann EJ; Baldwin RL; Ding H; Nagy A; Guha A; Gutmann DH
    Glia; 2003 May; 42(3):225-34. PubMed ID: 12673829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A calmodulin binding site in the tuberous sclerosis 2 gene product is essential for regulation of transcription events and is altered by mutations linked to tuberous sclerosis and lymphangioleiomyomatosis.
    Noonan DJ; Lou D; Griffith N; Vanaman TC
    Arch Biochem Biophys; 2002 Feb; 398(1):132-40. PubMed ID: 11811958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant expression of HMGA2 in uterine leiomyoma associated with loss of TSC2 tumor suppressor gene function.
    Hunter DS; Klotzbücher M; Kugoh H; Cai SL; Mullen JP; Manfioletti G; Fuhrman U; Walker CL
    Cancer Res; 2002 Jul; 62(13):3766-72. PubMed ID: 12097287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and prognostic value of tuberous sclerosis complex 2 gene product tuberin in human pancreatic cancer.
    Kataoka K; Fujimoto K; Ito D; Koizumi M; Toyoda E; Mori T; Kami K; Doi R
    Surgery; 2005 Sep; 138(3):450-5. PubMed ID: 16213898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HMB-45 and tuberin in hamartomas associated with tuberous sclerosis.
    Kimura N; Watanabe M; Date F; Kitamoto T; Kumura I; Horii A; Nagura H
    Mod Pathol; 1997 Sep; 10(9):952-9. PubMed ID: 9310961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tuberin is a component of lipid rafts and mediates caveolin-1 localization: role of TSC2 in post-Golgi transport.
    Jones KA; Jiang X; Yamamoto Y; Yeung RS
    Exp Cell Res; 2004 May; 295(2):512-24. PubMed ID: 15093748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of the neoplastic phenotype by replacement of the Tsc2 gene in Eker rat renal carcinoma cells.
    Orimoto K; Tsuchiya H; Kobayashi T; Matsuda T; Hino O
    Biochem Biophys Res Commun; 1996 Feb; 219(1):70-5. PubMed ID: 8619830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.